Skip to main content
Spyre Therapeutics, Inc. (SYRE)
NASDAQ: SYRE · Real-Time Price · USD
23.34
-0.25 (-1.06%)
Dec 24, 2024, 1:00 PM EST - Market closed

Spyre Therapeutics Revenue

In the year 2023, Spyre Therapeutics had annual revenue of $886.00K, down -61.96%.

Revenue (ttm)
$886.00K
Revenue Growth
-61.96%
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
30
Market Cap
1.37B

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 2023886.00K-1.44M-61.96%
Dec 31, 20222.33M-16.41M-87.57%
Dec 31, 202118.74M--
Dec 31, 2020---
Dec 31, 2019---
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro
Dec 31, 2014 Pro Pro Pro
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
AdaptHealth 3.26B
Novavax 885.19M
U.S. Physical Therapy 639.06M
InMode 423.75M
MiMedx Group 342.80M
Immunocore Holdings 296.31M
Schrödinger 193.35M
RxSight 128.29M
Revenue Rankings

SYRE News

More News